1. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute
   Kei Sonehara et al, 2019, Chemotherapy CrossRef
2. Diagnostic Test Accuracy of Glasgow Prognostic Score as a Prognostic Factor for Renal Cell Carcinoma
   Sun Il Kim et al, 2020, American Journal of Clinical Oncology CrossRef
3. Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
   Tao Li et al, 2020, Pathology & Oncology Research CrossRef
4. Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity
   John Davies et al, 2022, Pigment Cell & Melanoma Research CrossRef
5. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
   Tongyu Tong et al, 2020, Frontiers in Oncology CrossRef
6. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis
   Wei Zhou et al, 2019, PLOS ONE CrossRef
7. Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
   Go Kaneko et al, 2019, Japanese Journal of Clinical Oncology CrossRef
8. Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre
   Mark Stares et al, 2023, Cancer Medicine CrossRef
9. Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients
   Takashi Matsuki et al, 2020, Cancer Medicine CrossRef
10. Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis
    Chun-Xian Chen et al, 2021, Aging CrossRef
11. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis
    Yuan Shao et al, 2020, BMC Urology CrossRef
12. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients
    Kazuki Abe et al, 2022, European Journal of Clinical Pharmacology CrossRef